Emil D Kakkis insider trades

Open-market stock purchases and sales by Emil D Kakkis, President & CEO at Ultragenyx Pharmaceutical Inc, from SEC Form 4 filings since Feb 5, 2014.

Track record: 0% of 3 scored buys are up 5% or more since purchase, averaging -50%.

Recent trades

DateStockTradeValue
Apr 16, 2026RARE Ultragenyx Pharmaceutical IncBought (not open market)—
Apr 16, 2026RARE Ultragenyx Pharmaceutical IncBought (not open market)—
Mar 2, 2026RARE Ultragenyx Pharmaceutical IncSold$1.2M
Mar 1, 2026RARE Ultragenyx Pharmaceutical IncBought (not open market)—

Companies traded

  • RARE Ultragenyx Pharmaceutical Inc: 3 buys, 53 sales, last Apr 16, 2026

Get free alerts when Emil D Kakkis files a new trade →